MXCT vs WELL · rev $38.6M vs P/E 100, rev $10.84B
MaxCyte Inc (MXCT) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
MXCT currently screens at market cap $124.3M. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the MXCT and WELL stock pages for the full models.
Not investment advice.